Breakthroughs in medicine rarely begin with billion-dollar laboratories. They begin with a single researcher, a bold idea, and the courage to pursue it.
The Movement Disorders Foundation (MDF) exists to fund that critical first step.
Accelerating Breakthroughs in Movement Disorders
Since 2018, MDF, a 501(c)3 nonprofit corporation, has accelerated scientific discovery in Parkinson’s disease, Huntington’s disease, dystonia, essential tremor, and related neurological disorders by supporting innovative research at the moment it matters most—when promising ideas are too early, too unconventional, or too risky for traditional funding.
Founded by internationally recognized movement disorders neurologist Rajeev Kumar, MDF focuses on identifying and supporting the next generation of scientific pioneers working to transform how these diseases are understood, treated, and ultimately prevented.
Investing in Discovery Before the Breakthrough
Most research funding supports established laboratories pursuing incremental advances. Yet history shows that transformative discoveries—from insulin to deep brain stimulation—often begin with bold ideas from individual investigators challenging conventional thinking.
MDF fills this critical gap.
We identify “undiscovered pioneers”—scientists with high-potential ideas that could lead to disease-modifying therapies but lack the early funding needed to prove their concept. By providing targeted seed funding, the Foundation helps these projects generate the evidence required to attract larger institutional and industry investment.
In this way, MDF operates much like a seed-stage investor in biomedical innovation, accelerating promising ideas toward credible proof of concept and real clinical impact.
Since 2020, we have awarded over $850,000 to early-career research scientists whose high-risk, high-reward projects have encouraged cross-disease investigation and driven new insights into the pathophysiology, causes, and treatment of multiple movement disorders.
Why the Need Is Urgent
Neurological movement disorders are among the fastest-growing areas of disease worldwide. The prevalence of Parkinson’s disease alone is projected to more than double globally in the coming decades, yet research funding has not kept pace with the scale of the challenge.
Traditional funding systems are often slow and risk-averse, leaving early-career scientists and unconventional ideas without support. Without early investment, some of the most promising discoveries may never reach the stage where larger funding becomes possible.
MDF exists to ensure that transformative scientific ideas are not lost simply because they are too new or too bold.
Advancing Care for Patients and Families
In addition to funding research, MDF supports collaborative programs that improve care for people living with movement disorders.
Working with the Huntington’s Disease Society of America, the Foundation helps fund the Rocky Mountain Huntington’s Disease Center of Excellence, a multidisciplinary program providing coordinated medical care, counseling, and support for families affected by Huntington’s disease.
MDF also promotes clinical trials and observational studies that help bring new therapies closer to patients.
Small Foundation. Transformational Impact.
Though modest in size, the Movement Disorders Foundation plays a unique role in the scientific ecosystem—funding bold, early-stage ideas that larger institutions often cannot support.
By investing early, engaging donors directly in discovery, and fostering collaboration across the research community, MDF helps accelerate the scientific breakthroughs that will define the future of neurological medicine.
Together with visionary supporters, MDF is working to ensure that today’s bold ideas become tomorrow’s life-changing therapies.